Extracellular vesicles from bone marrow mesenchymal stromal cells of severe aplastic anemia patients attenuate hematopoietic functions of CD34+ hematopoietic stem and progenitor cells

Cell Biol Int. 2022 Nov;46(11):1970-1976. doi: 10.1002/cbin.11885. Epub 2022 Aug 23.

Abstract

Mesenchymal stromal cells (MSC) regulate hematopoiesis in the bone marrow (BM) niche and extracellular vesicles (EVs) released by BM-MSC are important mediators of the cross-talk between BM-MSC and hematopoietic stem and progenitor cells (HSPC). We have previously demonstrated that BM-MSC of severe aplastic anemia (SAA) patients have an altered expression of hematopoiesis regulatory molecules. In the present study, we observed that CD34+ HSPC when cocultured with BM-MSC EVs from aplastic anemia patients exhibited a significant reduction in colony-forming units (p = .001), cell proliferation (p = .002), and increased apoptosis (p > .001) when compared to coculture with BM-MSC EVs from controls. Collectively, our results highlight that EVs derived from the BM-MSC of SAA patients impair the hematopoiesis supporting function of HSPC.

Keywords: aplastic anemia; apoptosis; bone marrow mesenchymal stromal cells; colony forming units; extracellular vesicles; hematopoisis.

MeSH terms

  • Anemia, Aplastic* / metabolism
  • Antigens, CD34 / metabolism
  • Bone Marrow
  • Bone Marrow Cells
  • Extracellular Vesicles*
  • Hematopoietic Stem Cells
  • Humans
  • Mesenchymal Stem Cells*

Substances

  • Antigens, CD34